Haemonetics Corporation (HAE) — Capital Reinvestment Ratio

Latest as of March 2026: 0.25x

Haemonetics Corporation (HAE) has a Capital Reinvestment Ratio of 0.25x as of March 2026, meaning it reinvests 0% of its operating cash flow ($70.94 Million) in capital expenditures ($17.66 Million). Check how tangible is Haemonetics Corporation's equity to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.25x
Capex / Operating Cash Flow

Operating Cash Flow

$70.94 Million
USD

Capital Expenditures

$17.66 Million
USD

Data as of

Mar 2026
Most recent filing

Haemonetics Corporation Capital Reinvestment Ratio (1992–2026)

This chart tracks Haemonetics Corporation's Capital Reinvestment Ratio across 35 annual periods. For the full cash flow conversion analysis, see HAE cash flow conversion.

Annual Capital Reinvestment Ratio for Haemonetics Corporation (1992–2026)

Year-by-year Capital Reinvestment Ratio for Haemonetics Corporation from 1992 to 2026. See free cash flow generation of Haemonetics Corporation to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2026 0.11x $293.22 Million $32.78 Million ▼ -48.3%
2025 0.22x $181.72 Million $39.28 Million ▼ -40.7%
2024 0.36x $181.75 Million $66.30 Million ▼ -9.6%
2023 0.40x $273.06 Million $110.19 Million ▼ -28.0%
2022 0.56x $172.26 Million $96.51 Million ▲ +64.6%
2021 0.34x $108.81 Million $37.04 Million ▲ +10.5%
2020 0.31x $158.22 Million $48.76 Million ▼ -58.7%
2019 0.75x $159.28 Million $118.96 Million ▲ +120.0%
2018 0.34x $220.35 Million $74.80 Million ▼ -28.8%
2017 0.48x $159.74 Million $76.14 Million ▼ -43.3%
2016 0.84x $121.86 Million $102.41 Million ▼ -12.6%
2015 0.96x $127.18 Million $122.22 Million ▲ +82.1%
2014 0.53x $139.52 Million $73.65 Million ▼ -27.8%
2013 0.73x $85.07 Million $62.19 Million ▲ +58.5%
2012 0.46x $115.32 Million $53.20 Million ▲ +22.0%
2011 0.38x $123.45 Million $46.67 Million ▼ -12.3%
2010 0.43x $130.67 Million $56.30 Million ▼ -11.1%
2009 0.48x $116.36 Million $56.38 Million ▼ -34.9%
2008 0.74x $77.67 Million $57.79 Million ▲ +50.0%
2007 0.50x $83.56 Million $41.46 Million ▲ +15.5%
2006 0.43x $85.62 Million $36.77 Million ▲ +74.5%
2005 0.25x $71.21 Million $17.53 Million ▲ +32.5%
2004 0.19x $74.61 Million $13.86 Million ▼ -40.1%
2003 0.31x $43.67 Million $13.54 Million ▼ -53.7%
2002 0.67x $32.24 Million $21.60 Million ▲ +33.9%
2001 0.50x $61.01 Million $30.54 Million ▲ +14.8%
2000 0.44x $53.47 Million $23.32 Million ▼ -34.7%
1999 0.67x $33.70 Million $22.50 Million ▼ -33.2%
1998 1.00x $20.40 Million $20.40 Million ▼ -16.6%
1997 1.20x $26.70 Million $32.00 Million ▲ +233.4%
1996 0.36x $54.80 Million $19.70 Million ▼ -77.5%
1995 1.60x $15.60 Million $24.90 Million ▲ +88.2%
1994 0.85x $27.00 Million $22.90 Million ▲ +73.0%
1993 0.49x $35.90 Million $17.60 Million ▼ -19.2%
1992 0.61x $18.80 Million $11.40 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow